Dr Mischoulon and colleagues reply

Journal of Clinical Psychiatry

Volumn 75, Issue 11, 2014, Pages e1328-e1329

  Mischoulon, David ^a   Price, Lawrence H ^b   Carpenter, Linda L ^b   Tyrka, Audrey R ^b   Papakostas, George I ^a   Fava, Maurizio ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO; S ADENOSYLMETHIONINE; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ALTERNATIVE MEDICINE; CLINICAL RESEARCH; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; MAJOR DEPRESSION; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; REMISSION; STUDY DESIGN; DEPRESSIVE DISORDER, MAJOR; FEMALE; MALE;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; S-ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITORS;

EID: 84927565582     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.14lr09266a     Document Type: Letter

References (5)

1. Mischoulon D, Price LH, Carpenter LL, et al. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-l-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry. 2014;75(4):370-376. doi:10.408/JCP.13m08591 PubMed
2. Papakostas GI, Mischoulon D, Shyu I, et al. S-Adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: A double-blind, randomized clinical trial. Am J Psychiatry. 2010;167(8):942-948. doi:10.176/api.ajp.209.0908198 PubMed
3. US Departments of Health and Human Services Agency for Healthcare Research and Quality (AHRQ). (2002). S-Adenosyl-l-methionine for treatment of depression, osteoarthritis, and liver disease. Summary, Evidence Report/Technology Assessment: Number 64. AHRQ Publication No. 02-E033. http://www.ahrq.gov/clinic/epcsums/samesum.htm . Updated August 2002. Accessed October 8, 2007.
4. Freeman MP, Fava M, Lake J, et al. Complementary and alternative medicine in major depressive disorder: The American Psychiatric Association Task Force report. J Clin Psychiatry. 2010;71(6):669-681. doi:10.408/JCP.10cs05959blu PubMed
5. Sarris J, I Papakostas G, Vitolo O, et al. S-Adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. J Affect Disord. 2014;164:76-81. doi:10.1016/j.jad.2014.03.041 PubMed